A. Rider

768 total citations
71 papers, 521 citations indexed

About

A. Rider is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, A. Rider has authored 71 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 19 papers in Genetics. Recurrent topics in A. Rider's work include BRCA gene mutations in cancer (19 papers), Advanced Breast Cancer Therapies (18 papers) and Bone health and treatments (12 papers). A. Rider is often cited by papers focused on BRCA gene mutations in cancer (19 papers), Advanced Breast Cancer Therapies (18 papers) and Bone health and treatments (12 papers). A. Rider collaborates with scholars based in United Kingdom, United States and Switzerland. A. Rider's co-authors include Adam Roughley, Gavin Taylor‐Stokes, Shrividya Iyer, Zvi Bentwich, David Geltner, Zev Sthoeger, Roger von Moos, Katie Lewis, Guy Hechmati and Yi Qian and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

A. Rider

66 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rider United Kingdom 12 308 184 80 59 51 71 521
Ulla Axdorph Sweden 14 271 0.9× 140 0.8× 64 0.8× 29 0.5× 79 1.5× 21 652
B. Strobl Germany 12 589 1.9× 186 1.0× 77 1.0× 91 1.5× 103 2.0× 24 808
Winette van der Graaf Netherlands 13 200 0.6× 251 1.4× 108 1.4× 46 0.8× 186 3.6× 26 593
Christopher Wynne New Zealand 15 295 1.0× 147 0.8× 83 1.0× 126 2.1× 82 1.6× 35 740
Lawrence Drudge‐Coates United Kingdom 12 384 1.2× 194 1.1× 46 0.6× 62 1.1× 17 0.3× 44 606
Mohamad Farid Singapore 13 323 1.0× 277 1.5× 54 0.7× 14 0.2× 80 1.6× 80 624
Sheila Breslin United States 10 264 0.9× 225 1.2× 39 0.5× 81 1.4× 16 0.3× 13 689
Hind M’rabti Morocco 14 355 1.2× 182 1.0× 102 1.3× 14 0.2× 21 0.4× 91 765
Niloufer Khan United States 8 504 1.6× 139 0.8× 39 0.5× 33 0.6× 64 1.3× 26 724
Dennis Chi United States 12 191 0.6× 111 0.6× 135 1.7× 90 1.5× 55 1.1× 33 871

Countries citing papers authored by A. Rider

Since Specialization
Citations

This map shows the geographic impact of A. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rider more than expected).

Fields of papers citing papers by A. Rider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rider. The network helps show where A. Rider may publish in the future.

Co-authorship network of co-authors of A. Rider

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rider. A scholar is included among the top collaborators of A. Rider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rider. A. Rider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Ravinder, et al.. (2024). Real-world clinical profile, RET mutation testing, treatments and patient-related outcomes for medullary thyroid cancer in Europe. European Thyroid Journal. 13(1). 1 indexed citations
2.
Fukuda, Naoki, Yoshinori Tanizawa, Urpo Kiiskinen, et al.. (2023). Real-World Clinical Profile, Treatment Patterns And Patient-Reported Outcomes for Thyroid Cancer in Japan. Future Oncology. 19(16). 1125–1137.
3.
Leith, Andrea, Urpo Kiiskinen, Allicia C. Girvan, et al.. (2022). Physician- and Patient-Reported Symptom Concordance and Association with Quality of Life in Hepatocellular Carcinoma. Future Oncology. 18(33). 3727–3740. 2 indexed citations
4.
Peipert, John Devin, et al.. (2022). Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients. Supportive Care in Cancer. 30(4). 3613–3623. 16 indexed citations
5.
Lux, Michael P., et al.. (2022). Real-World Multi-Country Study of BRCA1/2 Mutation Testing Among Adult Women with HER2-Negative Advanced Breast Cancer. Future Oncology. 18(9). 1089–1101. 2 indexed citations
6.
Quinn, Barry, et al.. (2021). Physical, Emotional and Social Pain Communication by Patients Diagnosed and Living with Multiple Myeloma. Pain Management. 12(1). 59–74. 5 indexed citations
7.
8.
9.
Lux, Michael P., et al.. (2020). 314P Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2−advanced breast cancer (ABC). Annals of Oncology. 31. S368–S369. 1 indexed citations
10.
Criscitiello, Carmen, Dean Spurden, A. Rider, et al.. (2020). 82P A multinational study of real-world treatment patterns among patients with early stage HR+/HER2- breast cancer (BC). Annals of Oncology. 31. S42–S43. 2 indexed citations
11.
12.
Method, Michael, A. Rider, Rhys Williams, & Jacqueline Brown. (2020). 174P Genomic testing, biomarkers and treatment patterns in early breast cancer. Annals of Oncology. 31. S312–S312. 1 indexed citations
13.
14.
Lewis, Katie, et al.. (2019). BRCA status, treatment patterns and outcomes in HER2- advanced breast cancer (ABC): A multi-country real-world study. Annals of Oncology. 30. iii51–iii52. 1 indexed citations
15.
Trigg, Andrew, Mark Kelly, Laura Iadeluca, et al.. (2019). PCN284 PSYCHOMETRIC EVALUATION AND SCORE INTERPRETATION OF THE NCCN-FACT OVARIAN SYMPTOM INDEX-18 IN PATIENTS WITH ADVANCED OVARIAN CANCER: REAL-WORLD EVIDENCE. Value in Health. 22. S110–S110. 1 indexed citations
16.
17.
Pike, James, Gregory A. Maglinte, A. Rider, et al.. (2017). Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan: A Preliminary Model. Value in Health. 20(9). A447–A447. 1 indexed citations
18.
Bennett, Bryan, et al.. (2017). Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?. Value in Health. 20(9). A456–A456. 4 indexed citations
19.
Roughley, Adam, et al.. (2014). Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer. Value in Health. 17(7). A650–A650. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulla Axdorph Breakdown of academic impact, for papers by B. Strobl Breakdown of academic impact, for papers by Winette van der Graaf Breakdown of academic impact, for papers by Christopher Wynne Breakdown of academic impact, for papers by Lawrence Drudge‐Coates Breakdown of academic impact, for papers by Mohamad Farid Breakdown of academic impact, for papers by Sheila Breslin Breakdown of academic impact, for papers by Hind M’rabti Breakdown of academic impact, for papers by Niloufer Khan Breakdown of academic impact, for papers by Dennis Chi
Rankless by CCL
2026